Medcolcanna Graduates Public Listing to NEO Exchange


Ryan Allway

November 17th, 2020

News, Top News


NEO-EXCHANGE

Company selects NEO as senior stock exchange of choice to access wider investor base and enhanced liquidity

NEO is pleased to announce it has granted final approval to Medcolcanna Organics Inc. (“ Medcolcanna,” “MCCN” or the “Company”), a vertically integrated Canadian cannabis company, to graduate to the NEO Exchange, following a voluntary delisting from the TSX Venture Exchange. Medcolcanna will begin trading today on the NEO Exchange under the symbol NEO:MCCN .

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201014005679/en/

Medcolcanna Organics Inc,, a vertically integrated Canadian cannabis company, celebrates a digital market open as it graduates to the NEO Exchange today, following a voluntary delisting from the TSX Venture Exchange. (Photo: Business Wire)Medcolcanna Organics Inc,, a vertically integrated Canadian cannabis company, celebrates a digital market open as it graduates to the NEO Exchange today, following a voluntary delisting from the TSX Venture Exchange. (Photo: Business Wire)

Founded in 2018, Medcolcanna believes in the healing power of cannabis and uses proprietary scientific formulas to deliver effective and accessible products to consumers around the world. MCCN has developed brands in a range of consumer verticals, including cosmetics, nutraceuticals, and Active Pharmaceutical Ingredients (API), boasting a capacity of 300 tons of dry flower processing per year – one of the largest extraction capacities of any licensed cannabis producer in Colombia. With fully licensed operations just outside of Bogota, Medcolcanna’s strategically located facilities enable optimal cultivation and production conditions while leveraging the low-cost structure in Colombia to expand its footprint in high value markets.

“This is a big day and an important milestone for Medcolcanna,” says Felipe de la Vega, CEO & Founder of Medcolcanna. “Having launched on the TSXV in May of 2019, we are now ready and excited to graduate to a senior exchange so we can better execute our aggressive growth strategy. We chose the NEO Exchange because they understand the complex needs of our business and industry. Their level of service has been indispensable in helping us reach this milestone. Through NEO, we expect to gain greater exposure to a wider investor base, increased access to capital, enhanced liquidity, and a true partner for the long term.”

With plans underway to enter the US market with low-cost cannabinoid raw materials in 2021, Medcolcanna has already developed a strategic network of pharmaceutical partnerships and other assets across the value chain to secure a leadership position in the global medicinal cannabis market. The company announced in July it had entered into a distribution and profit-sharing agreement with Greenstein Trading Ltd, a subsidiary of Greenstein Capital Ltd, to accelerate its strategic entry into the European cannabis market. Additionally, Medcolcanna SAS, a wholly-owned subsidiary of the company, recently announced a joint venture with Grupo Curativa SAS to distribute MCCN’s proprietary formulations to an extensive group of patients through Curativa’s network of doctors, starting this month.

“Medcolcanna is well-positioned to accelerate their growth in revenue and market share, both in Colombia and internationally,” commented Jos Schmitt, President and CEO of NEO. “By listing on the NEO Exchange, they’ll benefit from enhanced liquidity, greater visibility and investor awareness, a better experience for their investors, and exceptional service and support. Their strategic decision to graduate to the NEO Exchange is a testament to our relentless drive to deliver results, do what is right for capital raisers and investors, and champion the success of our issuers. We are honoured to be Medcolcanna’s senior stock exchange of choice, and look forward to working with them over the years to come.”

Investors can trade shares of NEO:MCCN through their usual investment channels, including discount brokerage platforms and full-service dealers. Click here to register for the October 29 th Q&A session with Medcolcanna to learn more about their unique value proposition and aggressive plans for growth.

The NEO Exchange is now home to 100 corporate and ETF listings, and consistently facilitates 12 per cent of all Canadian trading volume. Click here for a complete view of all NEO-listed securities.

About Medcolcanna Organics Inc.

Medcolcanna is a Canadian integrated medical cannabis company, with fully licensed operations based in Colombia. Led by a proven and successful management team, Medcolcanna has facilities in optimal growing locations which position the Company to become a global leader in the medical cannabis market. Medcolcanna employs state of the art organic agricultural technology and innovative pharmaceutical processes to produce high-quality products. The Company’s scalable production model and network of pharmaceutical partnerships globally ensures that they remain at the forefront of the medical cannabis industry.

Connect with Medcolcanna: Website LinkedIn

About NEO Exchange

NEO Exchange is a progressive stock exchange that brings together investors and capital raisers within a fair, efficient, and service-oriented environment. Fully operational since June 2015, NEO puts investors first and provides access to trading all Canadian-listed securities on a level playing field. The NEO Exchange lists senior companies and investment products seeking a stock exchange that enables investor trust, quality liquidity, and broad awareness including unfettered access to market data.

Connect with NEO: Website Twitter LinkedIn

Forward-Looking Statements

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “ forward-looking statements ”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects,” or “does not expect,” “is expected,” “anticipates” or “does not anticipate,” “plans,” “budget,” “scheduled,” “forecasts,” “estimates,” “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may,” “could,” “would,” “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and the delay or failure to receive board, shareholder or regulatory approvals for any proposed transaction, including those discussed herein. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release.

Media:
NEO
Adam Bornstein
E: [email protected]
P: 905.505.2540

Investor Relations:
Medcolcanna
Chris Reid, CFO
E: [email protected]
P: +571.642.9113

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading